Plasma Tumor Mutation Burden and Response to Pembrolizumab—Response
Year: 2021
Type: letter
Source: Clinical Cancer Research
Institution: University of Pennsylvania
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3039443907
